BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3988955)

  • 1. A bleeding disorder due to deficiency of alpha 2-antiplasmin.
    Kettle P; Mayne EE
    J Clin Pathol; 1985 Apr; 38(4):428-9. PubMed ID: 3988955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
    Williams EC
    Arch Intern Med; 1989 Aug; 149(8):1769-72. PubMed ID: 2475079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited disorders of the fibrinolytic pathway.
    Jain S; Acharya SS
    Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Congenital deficiency of the fibrinolysis inhibitor alpha 2-antiplasmin as a cause of hemorrhagic diathesis].
    Leebeek FW; Knot EA; Kluft C
    Ned Tijdschr Geneeskd; 1988 Jan; 132(4):167-70. PubMed ID: 3277073
    [No Abstract]   [Full Text] [Related]  

  • 5. Epsilon-aminocaproic acid in the treatment of patients with acute promyelocytic leukemia and acquired alpha-2-plasmin inhibitor deficiency.
    Schwartz BS; Williams EC; Conlan MG; Mosher DF
    Ann Intern Med; 1986 Dec; 105(6):873-7. PubMed ID: 3465267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A familial hemorrhagic diathesis in a Dutch family: an inherited deficiency of alpha 2-antiplasmin.
    Kluft C; Vellenga E; Brommer EJ; Wijngaards G
    Blood; 1982 Jun; 59(6):1169-80. PubMed ID: 6177359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blind spots of the diagnostic hemostasis screen].
    Levi M; Peters M; Briët E
    Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital deficiency of alpha 2-plasmin inhibitor in three sisters.
    Yoshioka A; Kamitsuji H; Takase T; Iida Y; Tsukada S; Mikami S; Fukui H
    Haemostasis; 1982; 11(3):176-84. PubMed ID: 7095605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency.
    Kordich L; Feldman L; Porterie P; Lago O
    Thromb Res; 1985 Dec; 40(5):645-51. PubMed ID: 4089832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective therapy with tranexamic acid in a case of chronic disseminated intravascular coagulation with acquired alpha2-antiplasmin deficiency associated with AL amyloidosis.
    Colucci G; Alberio L; Jahns M; Keller P; Steiner S; Rüsges-Wolter I; Lämmle B
    Thromb Haemost; 2009 Dec; 102(6):1285-7. PubMed ID: 19967165
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathophysiology of fibrinolysis.
    Juhan-Vague I; Alessi MC; Declerck PJ
    Baillieres Clin Haematol; 1995 Jun; 8(2):329-43. PubMed ID: 7549066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance.
    Carpenter SL; Mathew P
    Haemophilia; 2008 Nov; 14(6):1250-4. PubMed ID: 19141165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe postadenoidectomy bleeding revealing congenital alpha 2 antiplasmin deficiency in a child.
    Paqueron X; Favier R; Richard P; Maillet J; Murat I
    Anesth Analg; 1997 May; 84(5):1147-9. PubMed ID: 9141950
    [No Abstract]   [Full Text] [Related]  

  • 14. Congenital alpha(2)-plasmin inhibitor deficiencies: a review.
    Favier R; Aoki N; de Moerloose P
    Br J Haematol; 2001 Jul; 114(1):4-10. PubMed ID: 11472338
    [No Abstract]   [Full Text] [Related]  

  • 15. Intramedullary multiple hematomas in siblings with congenital alpha-2-plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid.
    Takahashi Y; Tanaka T; Nakajima N; Yoshioka A; Fukui H; Miyauchi Y; Mii Y; Tamai S
    Haemostasis; 1991; 21(5):321-7. PubMed ID: 1806461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal fibrinolysis recognized by thromboelastography in a case of severe bleeding with normal coagulation and platelet function, leads to detection of a novel SERPINF2 variant causing severe alpha-2-antiplasmin deficiency.
    Egan G; Pluthero FG; Bouskill V; Hilliard P; Drury LJ; Carcao MD; Kahr WHA
    Br J Haematol; 2019 Sep; 186(6):e198-e201. PubMed ID: 31282989
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolysis and acquired alpha-2 plasmin inhibitor deficiency in amyloidosis.
    Meyer K; Williams EC
    Am J Med; 1985 Sep; 79(3):394-6. PubMed ID: 4036990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 2-antiplasmin deficiency in a Sudanese child: a case report.
    Mohammed BAB
    J Med Case Rep; 2021 May; 15(1):238. PubMed ID: 33957960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminocaproic Acid and Tranexamic Acid Fail to Reverse Dabigatran-Induced Coagulopathy.
    Levine M; Huang M; Henderson SO; Carmelli G; Thomas SH
    Am J Ther; 2016; 23(6):e1619-e1622. PubMed ID: 26241703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A splicing donor site point mutation in intron 6 of the plasmin inhibitor (alpha2 antiplasmin) gene with heterozygous deficiency and a bleeding tendency.
    Hanss MM; Farcis M; Ffrench PO; de Mazancourt P; Dechavanne M
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):107-11. PubMed ID: 12544738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.